Why Is COMPASS PATHWAYS ADR ADR (CMPS) Stock Up Today?
By the Top Tier Newswire AI Desk · September 8, 2026 at 9:55 AM ET · reviewed against 1 wire stories
COMPASS PATHWAYS ADR ADR (CMPS) is up +7.01% in the latest session. Our newswire has captured 1 story on CMPS across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 56/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why CMPS stock is up today
Compass Pathways ADR (CMPS) rose 7.01% to $14.28 in morning trading on September 8, 2026, driven by news of a new U.S. healthcare provider education campaign and upcoming data presentations. The company announced it will debut the campaign and present new health economics and outcomes research (HEOR) data at the Psych Congress 2026. This event is expected to include seven posters covering real-world healthcare costs, provider perspectives, and 26-week COMP360 efficacy and safety data.
What Happened
The company revealed it will present new data at the Psych Congress, which is scheduled for September 14, 19. The posters will include real-world healthcare costs, provider perspectives, and 26-week COMP360 efficacy and safety data. This event is part of a broader educational campaign aimed at U.S. healthcare professionals regarding treatment-resistant depression. The news appears to have boosted investor sentiment, leading to a sharp intraday rally. The stock opened at $13.30 and quickly climbed to a session high of $14.28 shortly after 9:55 AM ET.
What The Data Shows
The stock’s intraday volume of 0.7 million shares is 0.2 times the 3-month daily average, indicating relatively low participation despite the sharp move. The price closed the session near its high, suggesting strong early buying pressure. CMPS is currently trading near the top of its 52-week range of $4.68 to $15.40. On the same day, the stock printed 14 fresh 52-week highs and two 52-week lows. The stock’s fundamentals remain challenging, with a market cap of $1.8 billion, unprofitable earnings (TTM EPS -3.61), and a beta of 2.55, which suggests high volatility relative to the market.
What To Watch
Investors should monitor the Psych Congress 2026 event from September 14, 19 for the presentation of new data and the reception of the company’s educational campaign. The event could provide further insight into the market’s perception of Compass Pathways’ treatment-resistant depression therapies.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
CMPS · Sep 8 session (5-min) · +8.21% vs prior close · updated 9:00 PM ETAI sentiment, last 36h · averaged over 1 story · 56/100 bullish
The headlines behind the move
Story flow · 1 story on the wire, last 36h · hover or tap a dot for the headline
5d agoStockTitanBULLISH 56Product/PR
Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026
Seven posters will include real-world healthcare costs, provider perspectives and 26-week COMP360 efficacy and safety data at Psych Congress Sept. 14-19.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →